Public-domain · open source
OpenJurist
← 694 F.3d 51 - Laserdynamics, Inc. v. Quanta Computer, Inc.

Laserdynamics, Inc. v. Quanta Computer, Inc.’s Empirical Analysis

694 F.3d 51 · 2012

Citation profile

79
cited by 79 later decisions
June 2025
most recently cited

22 federal appellate · 16 district ·

Relationships

Applies 28 U.S.C. § 1295 · 35 U.S.C. § 271 · 35 U.S.C. § 284 · 35 U.S.C. § 286 · 35 U.S.C. § 287

Relies on Daubert v. Merrell Dow Pharmaceuticals, Inc. · Ashcroft v. al-Kidd · Brooke Group Ltd. v. Brown & Williamson Tobacco Corp. · Aro Manufacturing Co. v. Convertible Top Replacement Co. · Thompson v. North American Stainless, LP

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 79 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

  1. “Where small elements of multi-component products are accused of infringement, calculating a royalty on the entire product carries a considerable risk that the patentee will be improperly compensated for non-infringing components of that product.”
    3 later decisions quote this exact passage · from the majority
  2. “[i]t is not enough to merely show that the [patented feature] is viewed as valuable, important, or even essential to the use of the [infringing product].”
    3 later decisions quote this exact passage · from the majority
  3. “Whether called 'product value apportionment' or anything else, the fact remains that [SAE's proposed] royalty was expressly calculated as a percentage of the entire market value of [the G650] rather than [of SAE's power-supply units] alone. This, by definition, is an application of the entire market value rule.”
    2 later decisions quote this exact passage · from the majority

How this case has been treated — in progress

Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.